Down-regulation of miR-219-5p increase the risk of cancer-related mortality in patients with prostate cancer

Conclusions miR-219-5p can be used as a biomarker to predict death risk in prostate cancer patients. The mortality risk prediction model constructed based on miR-219-5p has good consistency and validity in assessing patient prognosis.
Source: Postgraduate Medical Journal - Category: General Medicine Authors: Tags: Original research Source Type: research